Atlas Trials

Dose Ranging Trial to Determine the Safety and Efficacy of EMA401 in Patients With PHN

Clinical trial NCT02426411 · WITHDRAWN

Trial details

NCT number
NCT02426411
Sponsor
Spinifex Pharmaceuticals Pty Ltd
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Neuralgia, Postherpetic
Start date
2015-06-01
Primary completion
2016-10-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.